Tszfung Jackie Chan

Array ( [id] => 12506502 [patent_doc_number] => 09999609 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-06-19 [patent_title] => Methods for treating or preventing fatigue [patent_app_type] => utility [patent_app_number] => 15/268060 [patent_app_country] => US [patent_app_date] => 2016-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 12071 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15268060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15035373 [patent_doc_number] => 20190328691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-31 [patent_title] => ANTIBIOTIC THERAPY [patent_app_type] => utility [patent_app_number] => 15/760012 [patent_app_country] => US [patent_app_date] => 2016-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22904 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15760012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11471182 [patent_doc_number] => 20170057965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-02 [patent_title] => 'PYRROLOPYRIMIDINE DERIVATIVES AS TAM INHIBITORS' [patent_app_type] => utility [patent_app_number] => 15/247499 [patent_app_country] => US [patent_app_date] => 2016-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53682 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15247499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13672577 [patent_doc_number] => 20160375022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-29 [patent_title] => sGC STIMULATORS [patent_app_type] => utility [patent_app_number] => 15/245697 [patent_app_country] => US [patent_app_date] => 2016-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 150911 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15245697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13383503 [patent_doc_number] => 20180243293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-30 [patent_title] => Pharmaceutical combinations and their use [patent_app_type] => utility [patent_app_number] => 15/751954 [patent_app_country] => US [patent_app_date] => 2016-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8351 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15751954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11311631 [patent_doc_number] => 20160347738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-01 [patent_title] => 'sGC STIMULATORS' [patent_app_type] => utility [patent_app_number] => 15/215628 [patent_app_country] => US [patent_app_date] => 2016-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 189233 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15215628 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16755280 [patent_doc_number] => 10973806 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-13 [patent_title] => Methods of treating epithelioid cell tumors comprising administering a composition comprising nanoparticles comprising an mTOR inhibitor and an albumin [patent_app_type] => utility [patent_app_number] => 15/737936 [patent_app_country] => US [patent_app_date] => 2016-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37735 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15737936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14016321 [patent_doc_number] => 20190070154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-07 [patent_title] => NEW METHODS OF USE FOR AN ANTI-DIARRHEA AGENT [patent_app_type] => utility [patent_app_number] => 15/739396 [patent_app_country] => US [patent_app_date] => 2016-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11290 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15739396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12831904 [patent_doc_number] => 20180169140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-21 [patent_title] => ANTIBIOTIC COMPOSITIONS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 15/736675 [patent_app_country] => US [patent_app_date] => 2016-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12648 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15736675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15813891 [patent_doc_number] => 10632102 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-04-28 [patent_title] => Carbazole derivatives for the treatment of fibrotic diseases and related symptoms, and conditions thereof [patent_app_type] => utility [patent_app_number] => 15/736307 [patent_app_country] => US [patent_app_date] => 2016-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 21 [patent_no_of_words] => 5799 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 198 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15736307 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12790348 [patent_doc_number] => 20180155285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-07 [patent_title] => 3-AMINO-1,5,6,7-TETRAHYDRO-4H-INDOL-4-ONES [patent_app_type] => utility [patent_app_number] => 15/737182 [patent_app_country] => US [patent_app_date] => 2016-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61716 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15737182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12786040 [patent_doc_number] => 20180153849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-07 [patent_title] => MULTI-DRUG COMBINATIONS THAT ACT AS POTENT RADIOSENSITIZERS [patent_app_type] => utility [patent_app_number] => 15/735493 [patent_app_country] => US [patent_app_date] => 2016-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12852 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15735493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11929712 [patent_doc_number] => 09796697 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-24 [patent_title] => 'Tricyclic inhibitors of HIF-2-alpha and uses thereof' [patent_app_type] => utility [patent_app_number] => 15/177166 [patent_app_country] => US [patent_app_date] => 2016-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 39447 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15177166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11914219 [patent_doc_number] => 09782393 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-10 [patent_title] => 'Pharmaceutical compositions and methods for treating cancer and biomarkers for drug screening' [patent_app_type] => utility [patent_app_number] => 15/174393 [patent_app_country] => US [patent_app_date] => 2016-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 6226 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15174393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11348767 [patent_doc_number] => 20160367507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-22 [patent_title] => 'COMPOUNDS AND METHODS FOR TREATING ABERRANT ADRENOCORTICAL CELL DISORDERS' [patent_app_type] => utility [patent_app_number] => 15/170682 [patent_app_country] => US [patent_app_date] => 2016-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 13971 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15170682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11053255 [patent_doc_number] => 20160250218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-01 [patent_title] => 'PHARMACEUTICAL COMBINATION' [patent_app_type] => utility [patent_app_number] => 15/147929 [patent_app_country] => US [patent_app_date] => 2016-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8016 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15147929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15280015 [patent_doc_number] => 10512657 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-24 [patent_title] => Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases [patent_app_type] => utility [patent_app_number] => 15/137323 [patent_app_country] => US [patent_app_date] => 2016-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 53706 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15137323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16548516 [patent_doc_number] => 10881654 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-01-05 [patent_title] => Selective PFKFB4 inhibitors for the treatment of cancer [patent_app_type] => utility [patent_app_number] => 15/568751 [patent_app_country] => US [patent_app_date] => 2016-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 39 [patent_no_of_words] => 14797 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15568751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11023620 [patent_doc_number] => 20160220576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-04 [patent_title] => 'ISOXAZOLE COMPOUND FOR THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 15/096397 [patent_app_country] => US [patent_app_date] => 2016-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4944 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15096397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11090597 [patent_doc_number] => 20160287565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-06 [patent_title] => 'COMBINATION THERAPY FOR TREATING DISORDERS ASSOCIATED WITH EXCESS CORTISOL PRODUCTION' [patent_app_type] => utility [patent_app_number] => 15/092266 [patent_app_country] => US [patent_app_date] => 2016-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10145 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15092266 [rel_patent_id] =>[rel_patent_doc_number] =>)